Retirement Planning CO Of New England, Inc. Mannkind Corp Transaction History

Retirement Planning CO Of New England, Inc.

$181 Million
Q2 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2022 May 06, 2022	SELL	$2.62 - $4.45 $524 - $890	-200 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$4.05 - $5.37 $810 - $1,074	200 New	200 $0

Others Institutions Holding MNKD

# of Institutions

220

Shares Held

133M

Call Options Held

1.43M

Put Options Held

851K

Black Rock Inc. New York, NY

22.6M
Shares

$145 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

15.4M
Shares

$99.1 Million
0.0% of portfolio
Nitorum Capital, L.P. New York, NY

10.1M
Shares

$64.7 Million
5.97% of portfolio
State Street Corp Boston, MA

9.56M
Shares

$61.4 Million
0.0% of portfolio
Avoro Capital Advisors LLC New York, NY

8.76M
Shares

$56.2 Million
0.62% of portfolio

View Full List

About MANNKIND CORP

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.65B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

More about MNKD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Retirement Planning CO Of New England, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Retirement Planning CO Of New England, Inc. with notifications on news.

Account